Evaluation of vecabrutinib as a model for non-covalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia

Added 48 days ago (19.10.2021)
Authors: Billy Michael Chelliah Jebaraj; Annika Müller; Rashmi Priyadharshini Dheenadayalan; Sascha Endres; Philipp M Roessner; Felix Seyfried; Claudia Walliser; Martin Wist; Jialei Qi; Eugen Tausch; Daniel Mertens; Judith A Fox; Klaus-Michael Debatin; Lueder Hinrich Meyer; Pietro Taverna; Martina Seiffert; Peter Gierschik; Stephan Stilgenbauer
Journal: Blood
Read article